AU Patent

AU2014281702B2 — Delayed release cysteamine bead formulation

Assigned to Horizon Therapeutics US Holding LLC · Expires 2019-11-07 · 7y expired

What this patent protects

An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.

USPTO Abstract

An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014281702B2
Jurisdiction
AU
Classification
—
Expires
2019-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Horizon Therapeutics US Holding LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.